Log In
Print this Print this

Adynovate, Adynovi (BAX 855)

Also known as: BAX-855

  Manage Alerts
Collapse Summary General Information
Company Shire plc
DescriptionPegylated form of recombinant Factor VIII
Molecular Target Factor VIII
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationHemophilia
Indication DetailsPerioperative management of hemophilia A in adult and pediatric patients; Treat hemophilia A; Treat hemophilia A in pediatric patients; Treat patients ages <12 with hemophilia A
Regulatory Designation
PartnerNektar Therapeutics

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today